Related Experiment Video
Updated: Jan 24, 2026
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
1.4K
Echocardiography in Infiltrative Cardiomyopathy
Rebecca Perry1, Joseph B Selvanayagam1
1College of Medicine, Flinders University, Adelaide, SA, Australia; Department of Cardiovascular Medicine, Flinders Medical Centre, Southern Adelaide Local Health Network, Adelaide, SA, Australia; Cardiac Imaging Research, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
Heart, Lung & Circulation
|May 22, 2019
Summary
Infiltrative cardiac deposition diseases cause left ventricular wall thickening, leading to heart failure. Echocardiography aids in diagnosing and determining the prognosis of these rare conditions.
Area of Science:
- Cardiology
- Medical Imaging
- Genetics
Background:
- Left ventricular (LV) wall thickening can result from physiological or pathological processes.
- Infiltrative cardiac deposition diseases, a group of rare inherited and acquired disorders, are a significant cause of pathological LV thickening.
- These conditions often lead to impaired cardiac function and heart failure, with a generally poor prognosis unless diagnosed and treated early.
Purpose of the Study:
- To review the role of echocardiography in the diagnosis of infiltrative cardiac deposition diseases.
- To highlight echocardiography's utility in assessing the prognosis of patients with these conditions.
- To discuss the characteristic echocardiographic features and hemodynamic consequences of cardiac infiltration.
Main Methods:
- Review of existing literature on infiltrative cardiac deposition diseases and echocardiography.
- Analysis of echocardiographic findings in various infiltrative cardiomyopathies.
- Correlation of echocardiographic parameters with disease severity and patient outcomes.
Main Results:
- Echocardiography is a primary diagnostic tool for LV wall thickening due to infiltrative diseases.
- It provides crucial information on ventricular wall thickness, systolic and diastolic function.
- Characteristic echocardiographic patterns can suggest specific infiltrative diagnoses and help assess hemodynamic impact.
Conclusions:
- Echocardiography plays a vital role in the early diagnosis and prognostic evaluation of infiltrative cardiac deposition diseases.
- Prompt identification through echocardiography can potentially alter patient outcomes in specific cases.
- Understanding echocardiographic features is essential for managing patients with these rare cardiac conditions.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
509
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
509
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
451
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
451
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
496
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
496
01:29Cardiomyopathy V: Interprofessional Care
370
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
370
01:25Cardiomyopathy I: Introduction and Classification
545
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
545
01:29Cardiomyopathy VI: Nursing Management
332
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
332